New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganis...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (232 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 04166nam-a2201153z--4500 | ||
---|---|---|---|
001 | 993553550104498 | ||
005 | 20231214133635.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 202208s2022 xx |||||o ||| 0|eng d | ||
035 | |a (CKB)5600000000483079 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/91188 | ||
035 | |a (EXLCZ)995600000000483079 | ||
041 | 0 | |a eng | |
100 | 1 | |a Felgueiras, Helena |4 edt | |
245 | 1 | 0 | |a New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (232 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Chemistry |2 bicssc | |
653 | |a nanoparticles | ||
653 | |a 4-Nerolidylcatechol | ||
653 | |a antifungals | ||
653 | |a Microsporum canis | ||
653 | |a polycaprolactone | ||
653 | |a nanoprecipitation | ||
653 | |a silver nanoparticles | ||
653 | |a green synthesis method | ||
653 | |a Catharanthus roseus | ||
653 | |a Azadirachta indica | ||
653 | |a multidrug-resistant bacteria | ||
653 | |a wound healing | ||
653 | |a nosocomial infection | ||
653 | |a plant extract | ||
653 | |a grapefruit seed extract | ||
653 | |a antibacterial activity | ||
653 | |a fiber-hydrogel composite | ||
653 | |a biodegradable polymers | ||
653 | |a skin regeneration | ||
653 | |a drug delivery platforms | ||
653 | |a controlled release | ||
653 | |a tetramycin | ||
653 | |a antimicrobial activity | ||
653 | |a kiwifruit disease | ||
653 | |a conventional antibiotics | ||
653 | |a storage quality | ||
653 | |a gold nanoparticles | ||
653 | |a flavonoids | ||
653 | |a Gram-negative bacteria | ||
653 | |a DNA gyrase | ||
653 | |a in silico | ||
653 | |a multidrug-resistant Acinetobacter baumannii (MDR-AB) | ||
653 | |a hypertonic saline | ||
653 | |a antibiotics | ||
653 | |a biofilm | ||
653 | |a aerosol delivery | ||
653 | |a ultrahigh-throughput screening | ||
653 | |a live biosensors | ||
653 | |a antibiotic discovery | ||
653 | |a gram-negative pathogens | ||
653 | |a microfluidic droplet cocultivation | ||
653 | |a efficient promoters | ||
653 | |a polymyxins | ||
653 | |a colistin biosynthetic gene cluster | ||
653 | |a single cell | ||
653 | |a multi-omics | ||
653 | |a quercetin | ||
653 | |a magnesium-doped calcium silicate | ||
653 | |a osteogenic activity | ||
653 | |a bone regeneration and nanofiber scaffold | ||
653 | |a bulk-tank milk | ||
653 | |a mastitis | ||
653 | |a methicillin | ||
653 | |a milk | ||
653 | |a goat | ||
653 | |a somatic cell counts | ||
653 | |a staphylococcus | ||
653 | |a tetracycline | ||
653 | |a total bacterial counts | ||
653 | |a prosthetic joint infection | ||
653 | |a local prevention | ||
653 | |a allicin | ||
653 | |a chitosan | ||
653 | |a Sphaerotheca sp. | ||
653 | |a antibiotic | ||
653 | |a Rosa roxburghii | ||
653 | |a cyclic diphenylphosphonate | ||
653 | |a quinoline | ||
653 | |a DNA gyrase inhibitor | ||
653 | |a molecular docking | ||
653 | |a magnesium ion | ||
776 | |z 3-0365-4736-3 | ||
776 | |z 3-0365-4735-5 | ||
700 | 1 | |a Felgueiras, Helena |4 oth | |
906 | |a BOOK | ||
ADM | |b 2023-12-15 06:00:54 Europe/Vienna |f system |c marc21 |a 2022-08-13 21:17:26 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339474840004498&Force_direct=true |Z 5339474840004498 |b Available |8 5339474840004498 |